Aydogdu I - Search Results

1

Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease.

Karincaoglu Y, Kaya E, Esrefoglu M, Aydogdu I. Karincaoglu Y, et al. Among authors: aydogdu i. Leuk Lymphoma. 2003 Jun;44(6):1063-5. doi: 10.1080/1042819031000067864. Leuk Lymphoma. 2003. PMID: 12854911 Review.

2

Severe adverse skin reaction to chlorambucil in a patient with chronic lymphocytic leukemia.

Aydogdu I, Ozcan C, Harputluoglu M, Karincaoglu Y, Turhan O, Ozcanu A. Aydogdu I, et al. Anticancer Drugs. 1997 Jun;8(5):468-9. doi: 10.1097/00001813-199706000-00009. Anticancer Drugs. 1997. PMID: 9215610 No abstract available.

3

A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study.

Giles FJ, Shan J, Chen S, Advani SH, Supandiman I, Aziz Z, Caviles AP, Tee GY, Chasen MR, Fahed Z, Chaoj TY, Aydogdu I, Lynott AM. Giles FJ, et al. Among authors: aydogdu i. Leuk Lymphoma. 2000 Apr;37(3-4):367-77. doi: 10.3109/10428190009089437. Leuk Lymphoma. 2000. PMID: 10752988 Clinical Trial.

4

Bilateral transient hearing loss associated with vincristine therapy: case report.

Aydogdu I, Ozturan O, Kuku I, Kaya E, Sevinc A, Yildiz R. Aydogdu I, et al. J Chemother. 2000 Dec;12(6):530-2. doi: 10.1179/joc.2000.12.6.530. J Chemother. 2000. PMID: 11154039

5

Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.

Kuku I, Kaya E, Sevinc A, Aydogdu I. Kuku I, et al. Among authors: aydogdu i. J Eur Acad Dermatol Venereol. 2002 May;16(3):271-2. doi: 10.1046/j.1468-3083.2002.00485.x. J Eur Acad Dermatol Venereol. 2002. PMID: 12195570

6

Isolated thrombocytopenia: the presenting finding of typhoid fever.

Serefhanoglu K, Kaya E, Sevinc A, Aydogdu I, Kuku I, Ersoy Y. Serefhanoglu K, et al. Among authors: aydogdu i. Clin Lab Haematol. 2003 Feb;25(1):63-5. doi: 10.1046/j.1365-2257.2003.00478.x. Clin Lab Haematol. 2003. PMID: 12542445

7

Bilateral hearing loss during vincristine therapy: a case report.

Kalcioglu MT, Kuku I, Kaya E, Oncel S, Aydogdu I. Kalcioglu MT, et al. Among authors: aydogdu i. J Chemother. 2003 Jun;15(3):290-2. doi: 10.1179/joc.2003.15.3.290. J Chemother. 2003. PMID: 12868558

8

Transient severe thrombocytopenia in a patient on CAPD after intravenous iron administration.

Taskapan H, Bahceci F, Taskapan C, Sahin I, Kaya E, Aydogdu I. Taskapan H, et al. Among authors: aydogdu i. Perit Dial Int. 2003 Jul-Aug;23(4):408-9. Perit Dial Int. 2003. PMID: 12968855 No abstract available.

9

Blastic natural killer cell leukaemia with skin involvement: a case report.

Kaya E, Ozcan H, Kuku I, Dikilitas M, Sevinc A, Aydogdu I. Kaya E, et al. Among authors: aydogdu i. J Eur Acad Dermatol Venereol. 2004 Jan;18(1):86-8. doi: 10.1111/j.1468-3083.2004.00707.x. J Eur Acad Dermatol Venereol. 2004. PMID: 14678540

10

Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myeloma.

Kuku I, Aydogdu I, Bayraktar N, Kaya E, Akyol O, Erkurt MA. Kuku I, et al. Among authors: aydogdu i. Cell Biochem Funct. 2005 Jan-Feb;23(1):47-50. doi: 10.1002/cbf.1127. Cell Biochem Funct. 2005. PMID: 15386538 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters